ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Avigan trials will continue in Japan, with drug efficacy unclear

University seeks evidence as Abe government stands by goal of May approval

Data showing the effectiveness of Avigan (generic name: Favipiravir) would need to come forward within the next several days to meet the May approval target.   © Reuters

TOKYO -- A Japanese team testing the flu drug Avigan as a treatment for the new coronavirus said Wednesday more time was needed to determine its effectiveness, while the government stood by a goal of approving the medication's use this month.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more